New functional and structural insights from updated mutational databases for complement factor H, Factor I, membrane cofactor protein and C3

Bioscience Reports

Volumn 34, Issue 5, 2014, Pages 635-649

  Rodriguez, Elizabeth ^a   Rallapalli, Pavithra M ^a   Osborne, Amy J ^a   Perkins, Stephen J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Age related macular degeneration; Alternative pathway; Atypical haemolytic uraemic syndrome; Complement structure; Immunodeficiency diseases; Mutation database

Indexed keywords

CD46 PROTEIN, HUMAN; CFI PROTEIN, HUMAN; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; MEMBRANE COFACTOR PROTEIN;

CHEMISTRY; COMPLEMENT ALTERNATIVE PATHWAY; GENETICS; HUMAN; INFLAMMATION; MISSENSE MUTATION; NUCLEIC ACID DATABASE; PROTEIN DATABASE; PROTEIN TERTIARY STRUCTURE;

ANTIGENS, CD46; COMPLEMENT C3; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; COMPLEMENT PATHWAY, ALTERNATIVE; DATABASES, NUCLEIC ACID; DATABASES, PROTEIN; HUMANS; INFLAMMATION; MUTATION, MISSENSE; PROTEIN STRUCTURE, TERTIARY;

EID: 84949117415     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20140117     Document Type: Article

References (95)

1. Warwicker, P., Goodship, T. H. J., Donne, R. L., Pirson, Y., Nicholls, A., Ward, R. M. and Goodship, J. A. (1998) Genetic studies into inherited and sporadic haemolytic uraemic syndrome. Kidney Int. 53, 836-844 CrossRef PubMed
2. Saunders, R. E., Abarrategui-Garrido, C., Frémeaux-Bacchi, V., Goicoechea de Jorge, E., Goodship, T. H. J., López Trascasa, M., Noris, M., Ponce Castro, I. M., Remuzzi, G., Rodríguez de Córdoba, S. et al. (2007) The interactive Factor H - atypical haemolytic uraemic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models. Hum. Mutat. 28, 222-234 CrossRef PubMed
3. Kavanagh, D., Goodship, T. H. and Richards, A. (2013) Atypical hemolytic uremic syndrome. Semin. Nephrol. 33, 508-530 CrossRef PubMed
4. Frémeaux-Bacchi, V., Fakhouri, F., Garnier, A., Bienaime, F., Dragon-Durey, M. A., Ngo, S., Moulin, B., Servais, A., Provot, F., Rostaing, L. et al. (2013) Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin. J. Am. Soc. Nephrol. 8, 554-562 CrossRef PubMed
5. Saunders, R. E., Goodship, T. H. J., Zipfel, P. F. and Perkins, S. J. (2006) Factor H-associated haemolytic uraemic syndrome: a web database of the structural consequences of disease-associated mutations. Hum. Mutat. 27, 21-30 CrossRef PubMed
6. nd edn), IRL Press, Oxford
7. Rodríguez de Córdoba, S., Esparza-Gordillo, J., Goicoechea de Jorge, E., López-Trascasa, M. and Sánchez-Corral, P. (2004) The human complement factor H: functional roles, genetic variations and disease associations. Mol. Immunol. 41, 355-367 CrossRef PubMed
8. Ballermann, B. J. (1998) Endothelial cell activation. Kidney Int. 53, 1810-1826 CrossRef PubMed
9. Chamberlain, D., Ullman, C. G. and Perkins, S. J. (1998) Possible arrangement of the five domains in human complement factor I as determined by a combination of X-ray and neutron scattering and homology modelling. Biochemistry 37, 13918-13929 CrossRef PubMed
10. Frémeaux-Bacchi, V., Dragon-Durey, M. A., Blouin, J., Vigneau, C., Kuypers, D., Boudailliez, B., Loirat, C., Rondeau, E. and Fridman, W. H. (2004) Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome. J. Mol. Gen. 41, e84
11. Esparza-Gordillo, J., Goicoechea de, J. E., Buil, A., Carreras, B. L., Lopez-Trascasa, M., Sanchez-Corral, P. and Rodriguez de Cordoba, S. (2005) Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32. Hum. Mol. Gen. 14, 703-712 CrossRef
12. Kavanagh, D., Kemp, E. J., Mayland, E., Winney, R. J., Duffield, J. S., Warwick, G., Richards, A., Ward, R., Goodship, J. A. and Goodship, T. H. (2005) Atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol. 16, 2150-2155 CrossRef PubMed
13. Richards, A., Kemp, E. J., Liszewski, M. K., Goodship, J. A., Lampe, A. K., Decorte, R., Muslumanoglu, M. H., Kavukcu, S., Filler, G., Pirson, Y. et al. (2003) Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc. Natl. Acad. Sci. U. S. A. 100, 12966-12971 CrossRef PubMed
14. Noris, M., Brioschi, S., Caprioli, J., Todeschini, M., Bresin, E., Porrati, F., Gamba, S. and Remuzzi, G. (2003) Familial haemolytic uraemic syndrome and an MCP mutation. Lancet 362, 1542-1547 CrossRef PubMed
15. Caprioli, J., Noris, M., Brioschi, S., Pianetti, G., Castelletti, F., Bettinaglio, P., Mele, C., Bresin, E., Cassis, L., Gamba, S. et al. (2006) Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 108, 1267-1279 CrossRef PubMed
16. Frémeaux-Bacchi, V., Moulton, E. A., Kavanagh, D., Dragon-Durey, M. A., Blouin, J., Caudy, A., Arzouk, N., Cleper, R., Francois, M., Guest, G. et al. (2006) Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol. 17, 2017-2025 CrossRef PubMed
17. Frémeaux-Bacchi, V., Miller, E. C., Liszewski, M. K., Strain, L., Blouin, J., Brown, A. L., Moghal, N., Kaplan, B. S., Weiss, R. A., Lhotta, K. et al. (2008) Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 112, 4948-4952 CrossRef PubMed
18. Skerka, C., Chen, Q., Frémeaux-Bacchi, V. and Roumenina, L. T. (2013) Complement factor H related proteins (CFHRs). Mol. Immunol. 56, 170-180 CrossRef PubMed
19. Salvadori, M. and Bertoni, E. (2013) Update on hemolytic uremic syndrome: diagnostic and therapeutic recommendations. World J. Nephrol. 2, 56-76 CrossRef PubMed
20. Rallapalli, P. M., Kemball-Cook, G., Tuddenham, E. G., Gomez, K. and Perkins, S. J. (2013) A new interactive web database of mutations in coagulation factor IX provides novel insights into the phenotypes and genetics of haemophilia B. J. Thromb. Haemost. 11, 1329-1340 CrossRef PubMed
21. Janssen, B. J., Huizinga, E. G., Raaijmakers, H. C., Roos, A., Daha, M. R., Nilsson-Ekdahl, K., Nilsson, B. and Gros, P. (2005) Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 437, 505-511 CrossRef PubMed
22. Okemefuna, A. I., Nan, R., Gor, J. and Perkins, S. J. (2009) Electrostatic interactions contribute to the folded-back conformation of wild-type human Factor H. J. Mol. Biol. 391, 98-118 CrossRef PubMed
23. Nan, R., Ward, G., Gavigan, L., Miller, A., Gor, J., McKay, A. R., Lengyel, I. and Perkins, S. J. (2010) The His402 allotype of complement Factor H show similar self-association to the Tyr402 allotype. Mol. Immunol. 47, 2263 CrossRef
24. Persson, B. D., Schmitz, N. B., Santiago, C., Zocher, G., Larvie, M., Scheu, U., Casasnovas, J. M. and Stehle, T. (2010) Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens. PLoS Pathogen 6, e1001122 CrossRef
25. Roversi, P. I., Johnson, S., Caesar, J. J., McLean, F., Leath, K. J., Tsiftsoglou, S. A., Morgan, B. P., Harris, C. L., Sim, R. B. and Lea, S. M. (2011) Structural basis for complement factor I control and its disease-associated sequence polymorphisms. Proc. Natl. Acad. Sci. U. S. A. 108, 12839-12844 CrossRef PubMed
26. Perkins, S. J., Fung, K.-W. and Khan, S. (2014) Molecular interactions between complement factor H and its heparin and heparan sulphate ligands. Front. Immunol. 5, 126, 1-14 CrossRef
27. Claustres, M., Horaitis, O., Vanevski, M. and Cotton, R. G. (2002) Time for a unified system of mutation description and reporting: a review of locus-specific mutation databases. Genome Res. 12, 680-688 CrossRef PubMed
28. Caprioli, J., Castelletti, F., Bucchioni, S., Bettinaglio, P., Bresin, E., Pianetti, G., Gamba, S., Brioschi, S., Daina, E., Remuzzi, G. and Noris, M. (2003) Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Hum. Mol. Gen. 12, 3385-3395 CrossRef
29. Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M. et al. (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 102, 7227-7232 CrossRef PubMed
30. Yu, Y., Triebwasser, M. P., Wong, E. K., Schramm, E. C., Thomas, B., Reynolds, R., Mardis, E. R., Atkinson, J. P., Daly, M., Raychaudhuri, S. et al. (2014) Whole-exome sequencing identifies rare, functional CFH variants in families with macular degeneration. Hum. Mol. Gen. 23, 5283-5293 CrossRef
31. Matsumoto, T., Fan, X., Ishikawa, E., Ito, M., Amano, K., Toyoda, H., Komada, Y., Ohishi, K., Katayama, N., Yoshida, Y. et al. (2014) Analysis of patients with atypical hemolytic uremic syndrome treated at the Mie University Hospital: concentration of C3 p.I1157T mutation. Int. J. Hemotol., doi: 10.1007/s12185-014-1655-2 CrossRef
32. Bresin, E., Rurali, E., Caprioli, J., Sanchez-Corral, P., Frémeaux-Bacchi, V., Rodriguez de Cordoba, S., Pinto, S., Goodship, T. H., Alberti, M., Ribes, D. et al. (2013) Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype. J. Am. Soc. Nephrol. 24, 475-486 CrossRef PubMed
33. Dragon-Durey, M. A., Frémeaux-Bacchi, V., Loirat, C., Blouin, J., Niaudet, P., Deschenes, G., Coppo, P., Herman Fridman, W. and Weiss, L. (2004) Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases. J. Am. Soc. Nephrol. 15, 787-795 CrossRef PubMed
34. Chaudhary, P., Hepgur, M., Sarkissian, S., Smith, R. J. and Weitz, I. C. (2014) Atypical haemolytic-uraemic syndrome due to heterozygous mutations of CFH/CFHR1-3 and complement factor H 479. Blood Transfus. 12, 111-113 PubMed
35. Caprioli, J., Bettinaglio, P., Zipfel, P. F., Amadei, B., Daina, E., Gamba, S., Skerka, C., Marziliano, N., Remuzzi, G. and Noris, M. (2001) The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J. Am. Soc. Nephrol. 12, 297-307 PubMed
36. Hoffman, J. D., Cooke Bailey, J. N., D'Aoust, L. N., Cade, W., Ayala-Haedo, J., Fuzzell, M. D., Laux, R. A., Adams, L., Reinhart-Mercer, L., Caywood, L. et al. (2014) Rare complement Factor H variant associated with age-related macular degeneration in the Amish. Invest. Ophthal. Vis. Sci. 55, 4455-4460 CrossRef
37. Ault, B. H., Schmidt, B. Z., Fowler, N. L., Kashtan, C. E., Ahmed, A. E., Vogt, B. A. and Colten, H. R. (1997) Human factor H deficiency. Mutations in framework cysteine residues and block in H protein secretion and intracellular catabolism. J. Biol. Chem. 272, 25168-25175 CrossRef PubMed
38. Boon, C. J., Klevering, B. J., Hoyng, C. B., Zonneveld-Vrieling, M. N., Nabuurs, S. B., Blokland, E., Cremers, F. P. and den Hollander, A. I. (2008) Basal laminar drusen caused by compound heterozygous variants in the CFH gene. Am. J. Hum. Genet. 82, 516-523 CrossRef PubMed
39. Neumann, H. P., Salzmann, M., Bohnert-Iwan, B., Mannuelian, T., Skerka, C., Lenk, D., Bender, B. U., Cybulla, M., Riegler, P., Königsrainer, A. et al. (2003) Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries. J. Med. Genet. 40, 676-681 CrossRef PubMed
40. Maga, T. K., Nishimura, C. J., Weaver, A. E., Frees, K. L. and Smith, R. J. (2010) Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome. Hum. Mutat. 31, E1445-E1460 CrossRef PubMed
41. Mukai, S., Hidaka, Y., Hirota-Kawadobora, M., Matsuda, K., Fujihara, N., Takezawa, Y., Kubota, S., Koike, K., Honda, T. and Yamauchi, K. (2011) Factor H gene variants in Japanese: its relation to atypical hemolytic uremic syndrome. Mol. Immunol. 49, 48-55 CrossRef PubMed
42. Szilágyi, A., Kiss, N., Bereczki, C., Tálosi, G., Rácz, K., Túri, S., Györke, Z., Simon, E., Horváth, E., Kelen, K. et al. (2013) The role of complement in Streptococcus pneumoniae-associated haemolytic uraemic syndrome. Nephrol. Dial. Transplant 28, 2237-2245 CrossRef PubMed
43. Manuelian, T., Hellwage, J., Meri, S., Caprioli, J., Noris, M., Heinen, S., Jozsi, M., Neumann, H. P., Remuzzi, G. and Zipfel, P. F. (2003) Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. J. Clin. Investig. 111, 1181-1190 CrossRef
44. Heinen, S., Sanchez-Corral, P., Jackson, M. S., Strain, L., Goodship, J. A., Kemp, E. J., Skerka, C., Jokiranta, T. S., Meyers, K., Wagner, E. et al. (2006) De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome. Hum. Mutat. 27, 292-293 CrossRef PubMed
45. Ying, L., Katz, Y., Schlesinger, M., Carmi, R., Shalev, H., Haider, N., Beck, G., Sheffield, V. C. and Landau, D. (1999) Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome. Am. J. Hum. Genet. 65, 1538-1546 CrossRef PubMed
46. Alba-Domínguez, M., López-Lera, A., Garrido, S., Nozal, P., González-Granado, I., Melero, J., Soler-Palacín, P., Cámara, C. and López-Trascasa, M. (2012) Complement factor I deficiency: a not so rare immune defect: characterization of new mutations and the first large gene deletion. Orphanet. J. Rare Dis. 7, 42 CrossRef PubMed
47. Bienaime, F., Dragon-Durey, M. A., Regnier, C. H., Nilsson, S. C., Kwan, W. H., Blouin, J., Jablonski, M., Renault, N., Rameix-Welti, M. A., Loirat, C. et al. (2010) Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome. Kidney Int. 77, 339-349 CrossRef PubMed
48. van de Ven, J. P., Nilsson, S. C., Tan, P. L., Buitendijk, G. H., Ristau, T., Mohlin, F. C., Nabuurs, S. B., Schoenmaker-Koller, F. E., Smailhodzic, D., Campochiaro, P. A. et al. (2013) A functional variant in the CFI gene confers a high risk of age-related macular degeneration. Nat. Genet. 45, 813-817 CrossRef PubMed
49. Servais, A., Frémeaux-Bacchi, V., Lequintrec, M., Salomon, R., Blouin, J., Knebelmann, B., Grunfeld, J. P., Lesavre, P., Noel, L. H. and Fakhouri, F. (2007) Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J. Med. Genet. 44, 193-199 CrossRef PubMed
50. Nilsson, S. C., Karpman, D., Vaziri-Sani, F., Kristoffersson, A. C., Salomon, R., Provot, F., Frémeaux-Bacchi, V., Trouw, L. A. and Blom, A. M. (2007) A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation. Mol. Immunol. 44, 1835-1844 CrossRef PubMed
51. Vyse, T. J., Morley, B. J., Bartok, I., Theodoridis, E. L., Davies, K. A., Webster, A. D. and Walport, M. J. (1996) The molecular basis of hereditary complement factor I deficiency. J. Clin. Investig. 97, 925-933 CrossRef
52. Volokhina, E., Westra, D., Xue, X., Gros, P., van de Kar, N. and van den Heuvel, L. (2012) Novel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding. Ped. Nephrol. 27, 1519-1524 CrossRef
53. Botto, M., Fong, K. Y., So, A. K., Koch, C. and Walport, M. J. (1990) Molecular basis of polymorphisms of human complement component C3. J. Exp. Med. 172, 1011-1017 CrossRef PubMed
54. Yates, J. R., Sepp, T., Matharu, B. K., Khan, J. C., Thurlby, D. A., Shahid, H., Clayton, D. G., Hayward, C., Morgan, J., Wright, A. F. et al. (2007) Complement C3 variant and the risk of age-related macular degeneration. New Eng. J. Med. 357, 553-561 CrossRef
55. Helgason, H., Sulem, P., Duvvari, M. R., Luo, H., Thorleifsson, G., Stefansson, H., Jonsdottir, I., Masson, G., Gudbjartsson, D. F., Walters, G. B. et al. (2013) A rare nonsynonymous sequence variant in C3 is associated with high risk of age-related macular degeneration. Nat. Genet. 45, 1371-1374 CrossRef PubMed
56. Zhan, X., Larson, D. E., Wang, C., Koboldt, D. C., Sergeev, Y. V., Fulton, R. S., Fulton, L. L., Fronick, C. C., Branham, K. E., Bragg-Gresham, J. et al. (2013) Identification of a rare coding variant in complement 3 associated with age related macular degeneration. Nat. Genet. 45, 1375-1379 CrossRef PubMed
57. Roumenina, L. T., Frimat, M., Miller, E. C., Provot, F., Dragon-Durey, M. A., Bordereau, P., Bigot, S., Hue, C., Satchell, S. C., Mathieson, P. W. et al. (2012) A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function. Blood 119, 4182-4191 CrossRef PubMed
58. Noris, M., Caprioli, J., Bresin, E., Mossali, C., Pianetti, G., Gamba, S., Daina, E., Fenili, C., Castelletti, F., Sorosina, A. et al. (2010) Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin. J. Am. Soc. Nephrol. 5, 1844-1859 CrossRef PubMed
59. Sanchez Chinchilla, D., Pinto, S., Hoppe, B., Adragna, M., Lopez, L., Justa Roldan, M. L., Pena, A., Lopez Trascasa, M., Sanchez-Corral, P. and Rodriguez de Cordoba, S. (2014) Complement mutations in diacylglycerol kinase-epsilon-associated atypical hemolytic uremic syndrome. Clin. J. Am. Soc. Nephrol. 9, 1611-1619 CrossRef PubMed
60. Fan, X., Yoshida, Y., Honda, S., Matsumoto, M., Sawada, Y., Hattori, M., Hisanaga, S., Hiwa, R., Nakamura, F., Tomomori, M. et al. (2013) Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome. Mol. Immunol. 54, 238-246 CrossRef PubMed
61. Singer, L., Whitehead, W. T., Akama, H., Katz, Y., Fishelson, Z. and Wetsel, R. A. (1994) An amino acid substitution in the beta-chain (ASP549 to ASN) impairs C3 secretion. J. Biol. Chem. 269, 28494-28499 PubMed
62. Al-Akash, S. I., Almond, P. S., Savell, Jr, V. H., Gharaybeh, S. I. and Hogue, C. (2011) Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation. Pediatr. Nephrol. 26, 613-619 CrossRef PubMed
63. Lhotta, K., Janecke, A. R., Scheiring, J., Petzlberger, B., Giner, T., Fally, V., Wurzner, R., Zimmerhackl, L. B., Mayer, G. and Frémeaux-Bacchi, V. (2009) A large family with a gain-of-function mutation of complement C3 predisposing to atypical hemolytic uremic syndrome, microhematuria, hypertension and chronic renal failure. Clin. J. Am. Soc. Nephrol. 4, 1356-1362 CrossRef PubMed
64. Moore, I., Strain, L., Pappworth, I., Kavanagh, D., Barlow, P. N., Herbert, A. P., Schmidt, C. Q., Staniforth, S. J., Holmes, L. V., Ward, R. et al. (2010) Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome. Blood 115, 379-387 CrossRef PubMed
65. Brackman, D., Sartz, L., Leh, S., Kristoffersson, A. C., Bjerre, A., Tati, R., Frémeaux-Bacchi, V. and Karpman, D. (2011) Thrombotic microangiopathy mimicking membranoproliferative glomerulonephritis. Nephrol. Dial. Transplant. 26, 3399-3403 CrossRef PubMed
66. Poznansky, M. C., Clissold, P. M. and Lachmann, P. J. (1989) The difference between human C3F and C3S results from a single amino acid change from an asparagine to an aspartate residue at position 1216 on the alpha chain of the complement component, C3. J. Immunol. 143, 3860-3862 PubMed
67. Watanabe, Y., Matsui, N., Yan, K., Nishimukai, H., Tokunaga, K., Juji, T., Kobayashi, N. and Kohsaka, T. (1993) A novel C3 allotype C3′F02′has an amino acid substitution that may inhibit iC3b synthesis and cause C3-hypocomplementemia. Mol. Immunol. 30, 62
68. Duvvari, M. R., Paun, C. C., Buitendijk, G. H. S., Saksens, N. T. M., Volokhina, E. B., Ristau, T., Schoenmaker-Koller, F. E., van de Ven, J. P. H., Groenewoud, J. M. M., van den Heuvel, L. P. W. J. et al. (2014) Analysis of rare variants in the C3 gene in patients with age-related macular degeneration. PLoS ONE 9, e94165 CrossRef PubMed
69. Sartz, L., Olin, A. I., Kristoffersson, A. C., Stahl, A. L., Johansson, M. E., Westman, K., Frémeaux-Bacchi, V., Nilsson-Ekdahl, K. and Karpman, D. (2012) A novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome. J. Immunol. 188, 2030-2037 CrossRef PubMed
70. Azukaitis, K., Loirat, C., Malina, M., Adomaitiene, I. and Jankauskiene, A. (2014) Macrovascular involvement in a child with atypical hemolytic uremic syndrome. Pediatr. Nephrol. 29, 1273-1277 CrossRef PubMed
71. Kabsch, W. and Sander, C. (1983) Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22, 2577-2637 CrossRef PubMed
72. Wu, J., Wu, Y., Ricklin, D., Janssen, B. J. C., Lambris, J. D. and Gros, P. (2009) Structure of complement fragment C3b-factor H and implications for host protection by complement regulators. Nat. Immunol. 10, 728-734 CrossRef PubMed
73. Prosser, B. E., Johnson, S., Roversi, P., Herbert, A. P., Blaum, B. S., Tyrrell, J., Jowitt, T. A., Clark, S. J., Tarelli, E., Uhrin, D. et al. (2007) Structural basis for complement factor H - linked age-related macular degeneration. J. Exp. Med. 204, 2277-2283 CrossRef PubMed
74. Makou, E., Mertens, H. D., Maciejewski, M., Soares, D. C., Matis, I., Schmidt, C. Q., Herbert, A. P., Svergun, D. I. and Barlow, P. N. (2012) Solution structure of CCP modules 10-12 illuminates functional architecture of the complement regulator, factor H. J. Mol. Biol. 424, 295-312 CrossRef PubMed
75. Schmidt, C. Q., Herbert, A. P., Mertens, H. D. T., Guariento, M., Soares, D. C., Uhrin, D., Rowe, A. J., Svergun, D. I. and Barlow, P. N. (2010) The central portion of Factor H (Modules 10-15) is compact and contains a structurally deviant CCP module. J. Mol. Biol. 395, 105-122 CrossRef PubMed
76. Barlow, P. N., Norman, D. G., Steinkasserer, A., Horne, T. J., Pearce, J., Driscoll, P. C., Sim, R. B. and Campbell, I. D. (1992) Solution structure of the fifth repeat of factor H: a second example of the complement control protein module. Biochemistry 31, 3626-3634 CrossRef PubMed
77. Barlow, P. N., Steinkasserer, A., Norman, D. G., Kieffer, B., Wiles, A. P., Sim, R. B. and Campbell, I. D. (1993) Solution structure of a pair of complement modules by nuclear magnetic resonance. J. Mol. Biol. 232, 268-284 CrossRef PubMed
78. Morgan, H. P., Mertens, H. D., Guariento, M., Schmidt, C. Q., Soares, D. C., Svergun, D. I., Herbert, A. P., Barlow, P. N. and Hannan, J. P. (2012) Structural analysis of the C-terminal region (modules 18-20) of complement regulator factor H (FH). PLoS ONE 7, e32187 CrossRef PubMed
79. Jokiranta, T. S., Jaakola, V. P., Lehtinen, M. J., Parepalo, M., Meri, S. and Goldman, A. (2006) Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome. EMBO J. 25, 1784-1794 CrossRef PubMed
80. Casasnovas, J. M., Larvie, M. and Stehle, T. (1999) Crystal structure of two CD46 domains reveals an extended measles virus-binding surface. EMBO J. 18, 2911-2922 CrossRef PubMed
81. Perkins, S. J., Haris, P. I., Sim, R. B. and Chapman, D. (1988) A study of the structure of human complement component Factor H by Fourier transform infrared spectroscopy and secondary structure averaging methods. Biochemistry 27, 4004-4012 CrossRef PubMed
82. Khan, S., Nan, R., Gor, J., Mulloy, B. and Perkins, S. J. (2012) Bivalent and co-operative binding of complement Factor H to heparan sulphate and heparin. Biochem. J. 444, 417-428 CrossRef PubMed
83. Perkins, S. J., Nan, R., Li, K., Khan, S. and Miller, A. (2012) Complement factor H-ligand interactions: self-association, multivalency and dissociation constants. Immunobiology 217, 281-297 CrossRef PubMed
84. Kajander, T., Lehtinen, M. J., Hyvärinen, S., Bhattacharjee, A., Leung, E., Isenman, D. E., Meri, S., Goldman, A. and Jokiranta, T. S. (2011) Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement. Proc. Natl. Acad. Sci. U. S. A. 108, 2897-2902 CrossRef PubMed
85. Morgan, H. P., Schmidt, C. Q., Guariento, M., Blaum, B. S., Gillespie, D., Herbert, A. P., Kavanagh, D., Mertens, H. D., Svergun, D. I., Johansson, C. M. et al. (2011) Structural basis for engagement by complement factor H of C3b on a self surface. Nat. Struct. Mol. Biol. 18, 463-470 CrossRef PubMed
86. Okemefuna, A. I., Nan, R., Miller, A., Gor, J. and Perkins, S. J. (2010) Complement Factor H binds at two independent sites to C-reactive protein in acute-phase concentrations. J. Biol. Chem. 285, 1053-1065 CrossRef PubMed
87. Liszewski, M. K., Leung, M., Cui, W., Subramanian, V. B., Parkinson, J., Barlow, P. N., Manchester, M. and Atkinson, J. P. (2000) Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46). J. Biol. Chem. 275, 37692-37701 CrossRef PubMed
88. Li, K., Gor, J. and Perkins, S. J. (2010) Self-association and domain rearrangements between complement C3 and C3u provide insight into the activation mechanism of C3. Biochem. J. 431, 63-72 CrossRef PubMed
89. Chen, H., Ricklin, D., Hammel, M., Garcia, B. L., McWhorter, W. J., Sfyroera, G., Wu, Y. Q., Tzekou, A., Li, S., Geisbrecht, B. V. et al. (2010) Allosteric inhibition of complement function by a staphylococcal immune evasion protein. Proc. Natl. Acad. Sci. U. S. A. 107, 17621-17626 CrossRef PubMed
90. Rodriguez, E., Nan, R., Li, K., Gor, J. and Perkins, S. J. (2014) A revised mechanism for the activation of complement C3 to C3b and a molecular explanation of the difference between their C3S and C3F polymorphic forms. Mol. Immunol. 61, 255
91. Martin, A. C., Facchiano, A. M., Cuff, A. L., Hernandez-Boussard, T., Olivier, M., Hainaut, P. and Thornton, J. M. (2002) Integrating mutation data and structural analysis of the TP53 tumor-suppressor protein. Hum. Mutat. 19, 149-164 CrossRef PubMed
92. Bajic, G., Yatime, L., Sim, R. B., Vorup-Jensen, T. and Andersen, G. R. (2013) Structural insight on the recognition of surface-bound opsonins by the integrin I domain of complement receptor 3. Proc. Natl. Acad. Sci. U. S. A. 110, 16426-16431 CrossRef PubMed
93. Delanghe, J. R., Speeckaert, R. and Speeckaert, M. M. (2014) Complement C3 and its polymorphism: biological and clinical consequences. Pathology 46, 1-10 CrossRef PubMed
94. Rallapalli, P. M., Orengo, C. A., Studer, R. A. and Perkins, S. J. (2014) Positive selection during the evolution of the blood coagulation factors in the context of their disease-causing mutations. Mol. Biol. Evol., in the press
95. Kosiol, C., Vinar, T., da Fonseca, R. R., Hubisz, M. J., Bustamante, C. D., Nielsen, R. and Siepel, A. (2008) Patterns of positive selection in six Mammalian genomes. PLoS Genet. 4, e1000144 CrossRef PubMed